{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:22:46Z","timestamp":1788535366497,"version":"build-2803163510"},"reference-count":42,"publisher":"American Chemical Society (ACS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A_166608"],"award-info":[{"award-number":["31003A_166608"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tetrahydroisoquinoline (THIQ) 6-O-sulfamate-based anticancer agents, inspired by the endogenous steroid 2-methoxyestradiol and its sulfamate derivatives, are further explored for antiproliferative and microtubule disruptor activity. Based on recently designed C3-methyl C7-methoxy-substituted THIQ derivatives, compounds with mono- and dichloro-substitutions on the pendant N-benzyl ring were synthesized and evaluated. Although improved antiproliferative activity was observed, for example, 4a versus 4b and 4b versus 8c, it was relatively modest. Compound 8c, a 2\u2032,5\u2032-dichlorobenzyl derivative was, however, identified as a promising antiproliferative agent with in vitro activities exceeding that of the parent steroid (e.g., GI50 90 nM in DU-145 cells) and was highly potent against a range of tumor cell lines (e.g., GI50 26 nM for OVCAR-3). 8c inhibited the polymerization of tubulin in vitro with an IC50 only twofold less potent than combretastatin A-4 and inhibited colchicine binding to tubulin. Tubulin polymerization assays showed the parent THIQ 4a to be only a very weak inhibitor, but a striking potency difference was seen between compounds with C2\u2032 methoxy and chloro substituents, whereas this was much smaller when these substituents were positioned at C5\u2032. To confirm the target in atomic detail and because 8c is a racemic mixture, an achiral parent THIQ 6-O-sulfamate derivative 10 was successfully cocrystallized with the \u03b1\u03b2-tubulin heterodimer. The derivative 10 binds at the colchicine site on tubulin, the first example of this compound class investigated in such detail, with its sulfamate group interacting with residues beyond the reach of colchicine itself, similar to a recently reported quinazolinone sulfamate derivative, 6a. The structure also suggests that for racemic C3-methyl-substituted THIQ derivatives, such as 8c, the (S)-enantiomer is likely to be preferentially accommodated within the colchicine site for steric reasons. The results further confirm the potential of nonsteroidal THIQ sulfamate derivatives for oncology and suggest that the mechanism of microtubule destabilization for the THIQ compound class is to prevent the curved-to-straight conformational transition of tubulin required for polymerization.<\/jats:p>","DOI":"10.1021\/acsomega.8b02879","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T15:10:45Z","timestamp":1547046645000},"page":"755-764","source":"Crossref","is-referenced-by-count":14,"title":["Tetrahydroisoquinoline Sulfamates as Potent Microtubule\nDisruptors: Synthesis, Antiproliferative and Antitubulin Activity\nof Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure"],"prefix":"10.1021","volume":"4","author":[{"given":"Wolfgang","family":"Dohle","sequence":"first","affiliation":[{"name":"University of Oxford , , Mansfield Road , ,","place":["Oxford, U.K., OX1 3QT"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea E.","family":"Prota","sequence":"additional","affiliation":[{"name":"Paul Scherrer Institute , , ,","place":["Villigen PSI, Switzerland, CH-5232"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gre\u0301gory","family":"Menchon","sequence":"additional","affiliation":[{"name":"Paul Scherrer Institute , , ,","place":["Villigen PSI, Switzerland, CH-5232"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Hamel","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Frederick National Laboratory for Cancer Research , , , ,","place":["Frederick, Maryland, United States, 21702"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6157-3687","authenticated-orcid":true,"given":"Michel O.","family":"Steinmetz","sequence":"additional","affiliation":[{"name":"Paul Scherrer Institute , , ,","place":["Villigen PSI, Switzerland, CH-5232"]},{"name":"University of Basel, Biozentrum , ,","place":["Basel, Switzerland, CH-4056"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-9135","authenticated-orcid":true,"given":"Barry V. L.","family":"Potter","sequence":"additional","affiliation":[{"name":"University of Oxford , , Mansfield Road , ,","place":["Oxford, U.K., OX1 3QT"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"2026090410074051100_cit1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1021\/ml200232c","article-title":"Steroidomimetic tetrahydroisoquinolines for the design\nof new microtubule disruptors","volume":"3","author":"Leese","year":"2011","journal-title":"ACS Med. Chem.\nLett."},{"key":"2026090410074051100_cit2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/cmdc.201300261","article-title":"Tetrahydroisoquinoline-based\nsteroidomimetic and chimeric microtubule disruptors","volume":"9","author":"Leese","year":"2013","journal-title":"ChemMedChem"},{"key":"2026090410074051100_cit3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/cmdc.201300412","article-title":"Synthesis, anti-tubulin\nand anti-proliferative SAR of C-3\/C-1 substituted tetrahydroisoquinolines","volume":"9","author":"Dohle","year":"2014","journal-title":"ChemMedChem"},{"key":"2026090410074051100_cit4","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1039\/c002558e","article-title":"Chimeric microtubule\ndisruptors","volume":"46","author":"Leese","year":"2010","journal-title":"Chem. Commun."},{"key":"2026090410074051100_cit5","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/cmdc.201402025","article-title":"Optimisation of tetrahydroisoquinoline-based\nchimeric microtubule disruptors","volume":"9","author":"Dohle","year":"2014","journal-title":"ChemMedChem"},{"key":"2026090410074051100_cit6","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1021\/jm050066a","article-title":"A-ring-substituted\nestrogen-3-O-sulfamates: Potent multitargeted anticancer\nagents","volume":"48","author":"Leese","year":"2005","journal-title":"J. Med. Chem."},{"key":"2026090410074051100_cit7","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1021\/jm070405v","article-title":"3,17-Disubstituted\n2-alkylestra-1,3,5(10)-trien-3-ol derivatives: Synthesis, in vitro\nand in vivo anticancer activity","volume":"50","author":"Bubert","year":"2007","journal-title":"J. Med. Chem."},{"key":"2026090410074051100_cit8","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.1039\/b810300c","article-title":"ffects of C-17 heterocyclic substituents\non the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: Synthesis, in vitro evaluation and computational\nmodelling","volume":"6","author":"Jourdan","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"2026090410074051100_cit9","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1021\/jm060705x","article-title":"2-Substituted estradiol bis-sulfamates,\nmultitargeted antitumor agents: Synthesis, in vitro SAR, protein crystallography,\nand in vivo activity","volume":"49","author":"Leese","year":"2006","journal-title":"J. Med. Chem."},{"key":"2026090410074051100_cit10","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1016\/j.bmcl.2004.04.027","article-title":"2-Alkylsulfanyl\nestrogen derivatives: Synthesis of a novel class of multi-targeted\nanti-tumour agents","volume":"14","author":"Leese","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026090410074051100_cit11","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.1021\/acs.jmedchem.5b00386","article-title":"Discovery and\ndevelopment of the aryl O-sulfamate pharmacophore\nfor oncology and women\u2019s health","volume":"58","author":"Thomas","year":"2015","journal-title":"J. Med.\nChem."},{"key":"2026090410074051100_cit12","doi-asserted-by":"publisher","first-page":"T233","DOI":"10.1530\/jme-18-0045","article-title":"Steroid\nsulphatase inhibition via aryl sulphamates: clinic progress, mechanism\nand future prospects","volume":"61","author":"Potter","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"2026090410074051100_cit13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1021\/acs.jmedchem.7b01474","article-title":"Quinazolinone-based\nanticancer agents: Synthesis, antiproliferative SAR, antitubulin activity,\nand tubulin co-crystal structure","volume":"61","author":"Dohle","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026090410074051100_cit14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0960-0760(95)00214-6","article-title":"Sulfamates of various estrogens are\nprodrugs with increased\nsystemic and reduced hepatic estrogenicity at oral application","volume":"55","author":"Elger","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"2026090410074051100_cit15","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/sj.bjc.6602130","article-title":"Pharmacokinetics\nof the nonsteroidal\nsteroid sulphatase inhibitor 667 COUMATE and its sequestration into\nred blood cells in rats","volume":"91","author":"Ireson","year":"2004","journal-title":"Br. J. Cancer"},{"key":"2026090410074051100_cit16","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b01990","article-title":"STX140\nand Non-Steroidal\nSulfamate Derivatives Inhibit Carbonic Anhydrase IX: Structure Activity\nOptimization of Isoform Selectivity","author":"Andring","year":"2019","journal-title":"J. Med.\nChem."},{"key":"2026090410074051100_cit17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s0960-0760(03)00035-9","article-title":"Growth inhibition of multi-drug-resistant breast cancer\ncells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate","volume":"84","author":"Suzuki","year":"2003","journal-title":"J. Steroid Biochem.\nMol. Biol."},{"key":"2026090410074051100_cit18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1158\/1078-0432.ccr-07-1717","article-title":"STX140 is efficacious\nin vitro and in vivo in taxane-resistant breast carcinoma cells","volume":"14","author":"Newman","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"2026090410074051100_cit19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/sj.bjc.6604873","article-title":"BCRP expression\ndoes not result in resistance to STX140 in vivo, despite the increased\nexpression of BCRP in A2780 cells in vitro after long-term STX140\nexposure","volume":"100","author":"Day","year":"2009","journal-title":"Br. J. Cancer"},{"key":"2026090410074051100_cit20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ijc.20045","article-title":"Inhibition of in vitro angiogenesis\nby 2-methoxy- and 2-ethyl-estrogen sulfamates","volume":"109","author":"Newman","year":"2004","journal-title":"Int. J. Cancer"},{"key":"2026090410074051100_cit21","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/sj.bjc.6603727","article-title":"In vivo\ninhibition of angiogenesis\nby sulphamoylated derivatives of 2-methoxyoestradiol","volume":"96","author":"Chander","year":"2007","journal-title":"Br. J. Cancer"},{"key":"2026090410074051100_cit22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from\na complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"key":"2026090410074051100_cit23","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1016\/s0040-4039(00)01130-8","article-title":"Efficient\ngeneral method for sulfamoylation\nof a hydroxyl group","volume":"41","author":"Okada","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"2026090410074051100_cit24","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2147\/dddt.s152718","article-title":"Modes of cell\ndeath induced by tetrahydroisoquinoline-based analogs in MDA-MB-231\nbreast and A549 lung cancer cell lines","volume":"12","author":"Nel","year":"2018","journal-title":"Drug\nDes. Dev. Ther."},{"key":"2026090410074051100_cit25","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/bjc.2015.345","article-title":"Targeted\nNF1 cancer therapeutics with multiple modes of action: Small molecule\nhormone-like agents resembling the natural anti-cancer metabolite,\n2-methoxyestradiol","volume":"113","author":"Shen","year":"2015","journal-title":"Br. J. Cancer"},{"key":"2026090410074051100_cit26a","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1126\/science.1230582","article-title":"Molecular\nmechanism of action of microtubule-stabilizing anticancer agents","volume":"339","author":"Prota","year":"2013","journal-title":"Science"},{"key":"2026090410074051100_cit26b","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.chempr.2016.12.005","article-title":"Structural basis of cis- and trans-combretastatin binding to tubulin","volume":"2","author":"Gaspari","year":"2017","journal-title":"Chem"},{"key":"2026090410074051100_cit26c","doi-asserted-by":"publisher","first-page":"10329","DOI":"10.1021\/acs.jmedchem.6b01268","article-title":"Potent antitumor activities and structure\nbasis of the chiral \u03b2-lactam bridged analogue of combretastatin\nA-4 binding to tubulin","volume":"59","author":"Zhou","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026090410074051100_cit27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1083\/jcb.201407095","article-title":"The contribution\nof \u03b1\u03b2-tubulin curvature\nto microtubule dynamics","volume":"207","author":"Brouhard","year":"2014","journal-title":"J. Cell Biol."},{"key":"2026090410074051100_cit28","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.jmb.2014.02.005","article-title":"The novel\nmicrotubule-destablizing drug BAL27862 binds to the colchicine site\nof tubulin with distinct effects on microtubule organization","volume":"426","author":"Prota","year":"2014","journal-title":"J. Mol. Biol."},{"key":"2026090410074051100_cit29","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1126\/science.1218231","article-title":"Linking crystallographic model and data quality","volume":"336","author":"Karplus","year":"2012","journal-title":"Science"},{"key":"2026090410074051100_cit30","doi-asserted-by":"publisher","first-page":"W615","DOI":"10.1093\/nar\/gkh398","article-title":"MOLPROBITY:\nStructure validation and all-atom contact analysis for nucleic acids\nand their complexes","volume":"32","author":"Davis","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"2026090410074051100_cit31","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1021\/bi00313a026","article-title":"Separation of active tubulin and microtubule-associated\nproteins by ultracentrifugation and isolation of a component causing\nthe formation of microtubule bundles","volume":"23","author":"Hamel","year":"1984","journal-title":"Biochemistry"},{"key":"2026090410074051100_cit32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/cbb:38:1:1","article-title":"Evaluation\nof antimitotic agents by quantitative comparisons of their effects\non the polymerization of purified tubulin","volume":"38","author":"Hamel","year":"2003","journal-title":"Cell\nBiochem. Biophys."},{"key":"2026090410074051100_cit33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/mol.53.1.62","article-title":"Structure-activity\nanalysis of the interaction of curacin A, the potent colchicine site\nantimitotic agent, with tubulin and effects of analogs on the growth\nof MCF-7 breast cancer cells","volume":"53","author":"Verdier-Pinard","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"2026090410074051100_cit34","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.1021\/bi00443a031","article-title":"Antimitotic\nnatural\nproducts combretastatin A-4 and combretastatin A-2: Studies on the\nmechanism of their inhibition of the binding of colchicine to tubulin","volume":"28","author":"Lin","year":"1989","journal-title":"Biochemistry"},{"key":"2026090410074051100_cit35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1083\/jcb.201211017","article-title":"Structural\nbasis of tubulin tyrosination by tubulin tyrosine ligase","volume":"200","author":"Prota","year":"2013","journal-title":"J. Cell Biol."},{"key":"2026090410074051100_cit36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/s0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr.,\nSect. D: Biol. Crystallogr."},{"key":"2026090410074051100_cit37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/s0907444909052925","article-title":"PHENIX: a comprehensive Phyton-based\nsystem for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr."},{"key":"2026090410074051100_cit38","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/s0907444904019158","article-title":"Coot: model-building\ntools for molecular graphics","volume":"60","author":"Elmsley","year":"2004","journal-title":"Acta Crystallogr."},{"key":"2026090410074051100_cit39","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/cber.19580910633","article-title":"U\u0308ber das hydrazidosulfamid\n(On hydrazidosulfamide)","volume":"91","author":"Appel","year":"1958","journal-title":"Chem. Ber."},{"key":"2026090410074051100_cit40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0960-0760(95)00244-8","article-title":"Heteroatom-substituted\nanalogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate\ninhibit estrone sulphatase by a different mechanism","volume":"57","author":"Woo","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.8b02879","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/4\/1\/755\/68376134\/acsomega.8b02879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/4\/1\/755\/68376134\/acsomega.8b02879.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:52:07Z","timestamp":1788533527000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/4\/1\/755\/1702825\/Tetrahydroisoquinoline-Sulfamates-as-Potent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,9]]},"published-print":{"date-parts":[[2019,1,31]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.8b02879","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]}}}